Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults.
Explore this paper's citation graph
Summary
Normal adults over the age of 23 can be immunized with a single, well-tolerated dose of A/New Jersey/76 vaccines, with a trend toward fewer systemic reactions in vaccines who had preexisting hemagglutination-inhibiting (HAI) antibodies to the vaccine virus in their sera.
- Type
- article
- Published
- 1977-12-01
- Cited by
- 38
- References
- 11
- OpenAlex
- https://openalex.org/W2014312055
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:11207400
Keywords
Reactogenicity, Immunogenicity, Virology, Virus, Medicine
References
- Comparative trial of influenza vaccines. II. Adverse reactions in children and adults.
- QUANTITATIVE ASPECTS OF THE RED BLOOD CELL AGGLUTINATION TEST FOR INFLUENZA VIRUS
- Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines.
- THE PRODUCTION OF FEVER BY INFLUENZAL VIRUSES
- Purification of Large Quantities of Influenza Virus by Density Gradient Centrifugation
- Summary of clinical trials of influenza virus vaccines in adults.
- Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man.
- Reactions to concentrated influenza virus vaccines.
- Systemic reactions to influenza B vaccine.
- The effect of nonaqueous solvents on the quaternary structure of viruses: a procedure for the simultaneous concentration, purification and disruption of influenza viruses.
- From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration: a status report on national immunization against influenza.
Cited by
- Vaccination against virus diseases
- Radiological findings of pneumonia in patients with swine-origin influenza A virus (H1N1)
- A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries
- Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women
- H1N1 influenza A. Preliminary evaluation in hospitalized patients in a secondary care facility in Saudi Arabia.
- AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
- An insight into the swine-influenza A (H1N1) virus infection in humans
- Antigenicity and reactivity of influenza A/New Jersey/8/76 virus vaccines in military volunteers at Fort Ord, California.
- Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization.
- Cross-Neutralizing Antibodies to Pandemic 2009 H1N1 and Recent Seasonal H1N1 Influenza A Strains Influenced by a Mutation in Hemagglutinin Subunit 2
- Comparative antigenicity and immunogenicity of 1976 influenza virus vaccines: results of mouse protection experiments.
- Clinical trials of monovalent influenza A/New Jersey/76 virus vaccines in adults: reactogenicity, antibody response, and antibody persistence.
- The impact of influenza A(H1N1)pdm09 infection on immunosuppressed patients.
- Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population.
- The cardiovascular manifestations of influenza: a systematic review.
- Influenza Virus Vaccines: Lessons from the 2009 H1N1 pandemic
- Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice
- 2009 pandemic characteristics and controlling experiences of influenza H1N1 virus 1 year after the inception in Hangzhou, China
- Summary of clinical trials of inactivated influenza vaccine - 1978.
- Acceptibility and antigenicity of influenza A/Victoria/75 virus vaccines in adults of different ages.
Related papers
- Safety and Immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme.
- Comparison of the reactogenicity and immunogenicity of two different dose levels of inactivated hepatitis a vaccine in healthy children and adolescents
- Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
- Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers.
- Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
- Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine.
- The virulence of West Nile virus and TP 21 virus and their application to a group B arbor virus vaccine.
- Competitive virus assay method for titration of noncytopathogenic bovine viral diarrhea viruses (END⁺ and END⁻ viruses).
- Production of a chimeric flavivirus that contains the major structural glycoprotein genes of T’Ho virus in the genetic background of Zika virus